{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:32:31Z","timestamp":1772127151692,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001673","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","award":["PNRR\\u2013 M4 C2 I1.1 -PRIN 2022CZTZ87 - CUP F53D23006660006"],"award-info":[{"award-number":["PNRR\\u2013 M4 C2 I1.1 -PRIN 2022CZTZ87 - CUP F53D23006660006"]}],"id":[{"id":"10.13039\/501100001673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001673","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","award":["2209 - GRT-2023\\u202FA"],"award-info":[{"award-number":["2209 - GRT-2023\\u202FA"]}],"id":[{"id":"10.13039\/501100001673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["M4-C2-Inv"],"award-info":[{"award-number":["M4-C2-Inv"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["1.5 -CUP F83B22000040006"],"award-info":[{"award-number":["1.5 -CUP F83B22000040006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pnpbp.2024.111234","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:26:38Z","timestamp":1735061198000},"page":"111234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Role of peroxisome proliferator-activated receptors \u03b1 and \u03b3 in mediating the beneficial effects of \u03b2-caryophyllene in a rat model of fragile X syndrome"],"prefix":"10.1016","volume":"136","author":[{"given":"Alessandro","family":"Rava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Buzzelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Feo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Ascone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melania","family":"Di Trapano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Schiavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pasquadibisceglie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Polticelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Manduca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111234_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1523\/JNEUROSCI.2945-14.2015","article-title":"Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats","volume":"35","author":"Achterberg","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2012.01.030","article-title":"The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats","volume":"1444","author":"Adamczyk","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pbb.2014.06.025","article-title":"The cannabinoid receptor 2 agonist, beta-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice","volume":"124","author":"Al Mansouri","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109602","article-title":"Disease-modifying effects of cannabidiol, beta-caryophyllene and their combination in Syn1-Cre\/Scn1a(WT\/A1783V) mice, a preclinical model of Dravet syndrome","volume":"237","author":"Alonso","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13229-019-0256-6","article-title":"Lower circulating endocannabinoid levels in children with autism spectrum disorder","volume":"10","author":"Aran","year":"2019","journal-title":"Mol. Autism"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature11737","article-title":"FMRP targets distinct mRNA sequence elements to regulate protein expression","volume":"492","author":"Ascano","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0035","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1523\/JNEUROSCI.6413-10.2011","article-title":"When is the hippocampus involved in recognition memory?","volume":"31","author":"Barker","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci9010011","article-title":"Closing the gender gap in fragile X syndrome: review on females with FXS and preliminary research findings","volume":"9","author":"Bartholomay","year":"2019","journal-title":"Brain Sci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0045","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajpath.2010.11.052","article-title":"beta-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARgamma pathway","volume":"178","author":"Bento","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrd.2017.221","article-title":"Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome","volume":"17","author":"Berry-Kravis","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s11689-022-09466-6","article-title":"A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)","volume":"14","author":"Berry-Kravis","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejphar.2011.10.029","article-title":"Peroxisome proliferator-activated receptor-alpha activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms","volume":"674","author":"Bhateja","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0065","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105906","article-title":"beta-Caryophyllene decreases neuroinflammation and exerts neuroprotection of dopaminergic neurons in a model of hemiparkinsonism through inhibition of the NLRP3 inflammasome","volume":"117","author":"Brand-Rubalcava","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061738","article-title":"Functional regulation of PPARs through post-translational modifications","volume":"19","author":"Brunmeir","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nm.3127","article-title":"Targeting the endocannabinoid system in the treatment of fragile X syndrome","volume":"19","author":"Busquets-Garcia","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-022-06286-3","article-title":"Psilocybin mitigates the cognitive deficits observed in a rat model of fragile X syndrome","volume":"240","author":"Buzzelli","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0090","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1073\/pnas.0900835106","article-title":"Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory","volume":"106","author":"Campolongo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fnsyn.2017.00015","article-title":"The search for an effective therapy to treat fragile X syndrome: dream or reality?","volume":"9","author":"Castagnola","year":"2017","journal-title":"Front. Synapt. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000362689","article-title":"beta-Caryophyllene ameliorates the Alzheimer-like phenotype in APP\/PS1 mice through CB2 receptor activation and the PPARgamma pathway","volume":"94","author":"Cheng","year":"2014","journal-title":"Pharmacology"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2014.08.002","article-title":"Assessing rodent hippocampal involvement in the novel object recognition task. A review","volume":"285","author":"Cohen","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/npp.2017.140","article-title":"Sex-dependent effects of Cannabis and cannabinoids: a translational perspective","volume":"43","author":"Cooper","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci14060592","article-title":"Endocannabinoid system changes throughout life: implications and therapeutic potential for autism, ADHD, and Alzheimer\u2019s disease","volume":"14","author":"Dallabrida","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0120","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1007\/s00213-020-05586-w","article-title":"Further evidence for the involvement of the PPARgamma system on alcohol intake and sensitivity in rodents","volume":"237","author":"Domi","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0125","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"Gertsch","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0130","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/cercor\/bhz029","article-title":"Deletion of the KH1 domain of Fmr1 leads to transcriptional alterations and attentional deficits in rats","volume":"29","author":"Golden","year":"2019","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/genes7090056","article-title":"Possible therapeutic doses of cannabinoid type 1 receptor antagonist reverses key alterations in fragile X syndrome mouse model","volume":"7","author":"Gomis-Gonzalez","year":"2016","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1037\/bul0000310","article-title":"A quantitative meta-analysis of face recognition deficits in autism: 40 years of research","volume":"147","author":"Griffin","year":"2021","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ab.2012.10.010","article-title":"Stain-free technology as a normalization tool in Western blot analysis","volume":"433","author":"Gurtler","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1037\/a0035988","article-title":"Fmr1 and Nlgn3 knockout rats: novel tools for investigating autism spectrum disorders","volume":"128","author":"Hamilton","year":"2014","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111639","article-title":"A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid","volume":"140","author":"Hashiesh","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0160","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/bph.14969","article-title":"Beta-caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents","volume":"177","author":"He","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0165","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1038\/s41380-023-02182-0","article-title":"PPARalpha and PPARgamma are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice","volume":"28","author":"Hempel","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0170","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ajmg.a.32848","article-title":"Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation","volume":"149A","author":"Hernandez","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11689-019-9277-x","article-title":"A phase 1\/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome","volume":"11","author":"Heussler","year":"2019","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0180","first-page":"10","article-title":"The endocannabinoid system and PPARs: focus on their signalling crosstalk, action and transcriptional regulation","author":"Iannotti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080326","article-title":"beta-caryophyllene mitigates collagen antibody induced arthritis (CAIA) in mice through a cross-talk between CB2 and PPAR-gamma receptors","volume":"9","author":"Irrera","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0190","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0195","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ncomms2045","article-title":"Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome","volume":"3","author":"Jung","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13229-018-0203-y","article-title":"Plasma anandamide concentrations are lower in children with autism spectrum disorder","volume":"9","author":"Karhson","year":"2018","journal-title":"Mol. Autism"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/molpharm.123.000668","article-title":"beta-Caryophyllene inhibits Monoacylglycerol lipase activity and increases 2-Arachidonoyl glycerol levels in vivo: a new mechanism of endocannabinoid-mediated analgesia?","volume":"105","author":"Klawitter","year":"2024","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0210","first-page":"247","article-title":"Abscisic acid interplays with PPARgamma receptors and ameliorates diabetes-induced cognitive deficits in rats","volume":"11","author":"Kooshki","year":"2021","journal-title":"Avicenna J. Phytomed."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0215","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41467-023-37112-9","article-title":"Structural basis of selective cannabinoid CB(2) receptor activation","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112012","article-title":"The cannabinoid receptor 2 agonist, beta-caryophyllene, improves working memory and reduces circulating levels of specific proinflammatory cytokines in aged male mice","volume":"372","author":"Lindsey","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0225","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fphar.2017.00002","article-title":"beta-Caryophyllene\/Hydroxypropyl-beta-Cyclodextrin inclusion complex improves cognitive deficits in rats with vascular dementia through the cannabinoid receptor type 2 -mediated pathway","volume":"8","author":"Lou","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114840","article-title":"Stain-free total-protein normalization enhances the reproducibility of Western blot data","volume":"654","author":"Maloy","year":"2022","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107176","article-title":"Cannabidiol and positive effects on object recognition memory in an in vivo model of fragile X syndrome: obligatory role of hippocampal GPR55 receptors","volume":"203","author":"Manduca","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"Pt 2","key":"10.1016\/j.pnpbp.2024.111234_bb0240","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neubiorev.2014.01.006","article-title":"Fragile X syndrome: from molecular pathology to therapy","volume":"46","author":"Maurin","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0245","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1093\/nar\/gky267","article-title":"HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein","volume":"46","author":"Maurin","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0250","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1101\/lm.1145209","article-title":"Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors","volume":"16","author":"Mazzola","year":"2009","journal-title":"Learn. Mem."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/npp.2017.143","article-title":"The role of the endocannabinoid system and genetic variation in adolescent brain development","volume":"43","author":"Meyer","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108758","article-title":"A selective peroxisome proliferator-activated receptor-gamma agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress","volume":"311","author":"Mirza","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092860","article-title":"Enhanced oral bioavailability of beta-caryophyllene in healthy subjects using the VESIsorb((R)) formulation technology, a novel self-emulsifying drug delivery system (SEDDS)","volume":"27","author":"Modinger","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuroscience.2021.10.029","article-title":"Brain expression, physiological regulation and role in motivation and associative learning of peroxisome proliferator-activated receptor gamma","volume":"479","author":"Moosecker","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0275","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12888-023-05422-3","article-title":"Cannabidiol (Epidyolex(R)) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials","volume":"24","author":"Muller","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0285","article-title":"Sex differences in autism Spectrum disorder: diagnostic, neurobiological, and behavioral features","volume":"13","author":"Napolitano","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0290","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41398-024-02815-0","article-title":"Multi-level profiling of the Fmr1 KO rat unveils altered behavioral traits along with aberrant glutamatergic function","volume":"14","author":"Ntoulas","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0295","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.bmcl.2015.05.025","article-title":"Peroxisome proliferator-activated receptor gamma (PPARgamma) has multiple binding points that accommodate ligands in various conformations: structurally similar PPARgamma partial agonists bind to PPARgamma LBD in different conformations","volume":"25","author":"Ohashi","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0300","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1126\/science.aaf7003","article-title":"Ventral CA1 neurons store social memory","volume":"353","author":"Okuyama","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0305","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1352\/2008.113:453-465","article-title":"Memory skills of boys with fragile X syndrome","volume":"113","author":"Ornstein","year":"2008","journal-title":"Am. J. Ment. Retard."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0310","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0315","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s11689-021-09394-x","article-title":"Increased 2-arachidonoyl-sn-glycerol levels normalize cortical responses to sound and improve behaviors in Fmr1 KO mice","volume":"13","author":"Pirbhoy","year":"2021","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0320","article-title":"V3 stain-free workflow for a practical, convenient, and reliable total protein loading control in western blotting","volume":"50948","author":"Posch","year":"2013","journal-title":"J. Visual. Exp."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cells12151927","article-title":"Early administration of the phytocannabinoid cannabidivarin prevents the neurobehavioral abnormalities associated with the Fmr1-KO mouse model of fragile X syndrome","volume":"12","author":"Premoli","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0330","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/ejp.1753","article-title":"Role of the endocannabinoid system in a mouse model of fragile X undergoing neuropathic pain","volume":"25","author":"Ramirez-Lopez","year":"2021","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0335","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fphar.2017.00200","article-title":"Cannabinoid modulation of memory consolidation in rats: beyond the role of cannabinoid receptor subtype 1","volume":"8","author":"Ratano","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063203","article-title":"Beta-caryophyllene, a cannabinoid receptor type 2 selective agonist, in emotional and cognitive disorders","volume":"25","author":"Ricardi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0345","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00787-023-02169-w","article-title":"Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review","volume":"33","author":"Rice","year":"2024","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114615","article-title":"Beta-caryophyllene mitigates the cognitive impairment caused by repeated exposure to aspartame in rats: putative role of BDNF-TrKB signaling pathway and acetylcholinesterase activity","volume":"453","author":"Rosa","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0355","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11481-014-9582-9","article-title":"PPARalpha signaling in the hippocampus: crosstalk between fat and memory","volume":"10","author":"Roy","year":"2015","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0360","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fncel.2019.00479","article-title":"Reward-related behavioral, neurochemical and electrophysiological changes in a rat model of autism based on prenatal exposure to Valproic acid","volume":"13","author":"Schiavi","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0365","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1080\/1028415X.2020.1819107","article-title":"Perinatal supplementation with omega-3 fatty acids corrects the aberrant social and cognitive traits observed in a genetic model of autism based on FMR1 deletion in rats","volume":"25","author":"Schiavi","year":"2022","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0370","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41386-022-01454-7","article-title":"Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats","volume":"48","author":"Schiavi","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0375","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1177\/1091581816655303","article-title":"Toxicological evaluation of beta-caryophyllene oil: subchronic toxicity in rats","volume":"35","author":"Schmitt","year":"2016","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0380","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1021\/jm058056x","article-title":"Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agents","volume":"50","author":"Sierra","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0385","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1111\/bph.14346","article-title":"Hippocampal PPARalpha is a novel therapeutic target for depression and mediates the antidepressant actions of fluoxetine in mice","volume":"175","author":"Song","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0390","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/FBP.0000000000000152","article-title":"Hyperactivity and lack of social discrimination in the adolescent Fmr1 knockout mouse","volume":"26","author":"Sorensen","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0395","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.nlm.2016.06.016","article-title":"Temporary inactivation reveals that the CA1 region of the mouse dorsal hippocampus plays an equivalent role in the retrieval of long-term object memory and spatial memory","volume":"133","author":"Stackman","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0400","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1093\/hmg\/ddv299","article-title":"Conserved hippocampal cellular pathophysiology but distinct behavioural deficits in a new rat model of FXS","volume":"24","author":"Till","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0405","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/jpet.108.141069","article-title":"Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats","volume":"328","author":"Trezza","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0410","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0415","series-title":"Coactivators in PPAR-Regulated Gene Expression. PPAR Research 2010","author":"Viswakarma","year":"2010"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0420","first-page":"10","article-title":"Neuroprotective effects of beta-caryophyllene against dopaminergic neuron injury in a murine model of Parkinson's disease induced by MPTP","author":"Viveros-Paredes","year":"2017","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2022.839931","article-title":"Regulation of social recognition memory in the hippocampal circuits","volume":"16","author":"Wang","year":"2022","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.pnpbp.2024.111234_bb0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbr.2014.09.050","article-title":"Neural circuitry for rat recognition memory","volume":"285","author":"Warburton","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0435","doi-asserted-by":"crossref","DOI":"10.1038\/srep27618","article-title":"Localization of PPAR isotypes in the adult mouse and human brain","volume":"6","author":"Warden","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0440","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/can.2015.0008","article-title":"Enhancement of anandamide-mediated endocannabinoid signaling corrects autism-related social impairment","volume":"1","author":"Wei","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0445","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.bmcl.2014.04.112","article-title":"Trans-Caryophyllene is a natural agonistic ligand for peroxisome proliferator-activated receptor-alpha","volume":"24","author":"Wu","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0450","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12035-014-8882-7","article-title":"PPARalpha agonist fenofibrate ameliorates learning and memory deficits in rats following global cerebral ischemia","volume":"52","author":"Xuan","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0455","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-023-01381-z","article-title":"AlphaFold2 and its applications in the fields of biology and medicine","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0460","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopha.2018.11.039","article-title":"Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: the role of CB2 and PPAR-gamma receptors","volume":"110","author":"Youssef","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pnpbp.2024.111234_bb0465","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200306","article-title":"Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder","volume":"11","author":"Zou","year":"2021","journal-title":"Open Biol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624003026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624003026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:29:01Z","timestamp":1745854141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624003026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":93,"alternative-id":["S0278584624003026"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111234","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of peroxisome proliferator-activated receptors \u03b1 and \u03b3 in mediating the beneficial effects of \u03b2-caryophyllene in a rat model of fragile X syndrome","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111234"}}